MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients
This study examined three polymorphisms—MECOM rs2201862, HBS1L-MYB rs9376092, and THRB-RARBrs4858647—and impact on the risk of developing MPN.
Am J Hematol
In The News
American Journal of Managed Care
In The Literature
American Journal of Hematology European Journal of Haematology